1. Simons K. Amblyopia characterization, treatment, and prophylaxis. Surv Ophthalmol. 2005; 50:123–66.
Article
2. von Noorden GK. Binocular vision and ocular motility. 6th ed.St. Louis: Mosby;2002. p. 246–97.
3. Korean Association for Pediatric Ophthalmology and Strabismus. Current concepts in strabismus. 2nd ed.Naewae Haksool;2008. p. 403–7.
4. Scott WE, Stratton VB, Fabre J. Full-time occlusion therapy for amblyopia. Am Orthopt J. 1980; 30:125–30.
Article
5. Foley-Nolan A, McCann A, O'Keefe M. Atropine penalisation versus occlusion as the primary treatment for amblyopia. Br J Ophthalmol. 1997; 81:54–7.
Article
6. Pediatric Eye Disease Investigator Group. A randomized trial of atropine vs. patching for treatment of moderate amblyopia in children. Arch Ophthalmol. 2002; 120:268–78.
7. Simons K, Stein L, Sener EC. . Full-time atropine, intermittent atropine, and optical penalization and binocular outcome in treatment of strabismic amblyopia. Ophthalmology. 1997; 104:2143–55.
Article
8. Scott WE, Kutschke PJ, Keech RV. . Amblyopia treatment outcomes. J AAPOS. 2005; 9:107–11.
Article
9. Simons K. Preschool vision screening: rationale, methodology and outcome. Surv Ophthalmol. 1996; 41:3–30.
Article
10. Oliver M, Gotesman N, Shimshoni M. Compliance and results of treatment for amblyopia in children more than 8 years old. CHILDREN. 1986; 197:75.
Article
11. Searle A, Norman P, Harrad R, Vedhara K. Psychosocial and clinical determinants of compliance with occlusion therapy for am-blyopic children. Eye (Lond). 2002; 16:150–5.
Article
12. Kim YH, Choi MY. The prospective comparison of the efficacy of intermittent atropine penalization and parttime occlusion therapy. J Korean Ophthalmol Soc. 2008; 49:958–66.
Article
13. Park SH, Chang HR. Decreased visual acuity of dominant eye compared to amblyopic eye during occlusion therapy. J Korean Ophthalmol Soc. 2010; 51:1374–9.
Article
14. Patil PA, Meenakshi S, Surendran TS. Refractory reverse am-blyopia with atropine penalization. Oman J Ophthalmol. 2010; 3:148–9.
Article